ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue

Molecular Metabolism

Volumn 3, Issue 6, 2014, Pages 642-651

  Kim, Min ^a   Neinast, Michael D ^a   Frank, Aaron P ^a   Sun, Kai ^a   Park, Jiyoung ^a,b   Zehr, Jordan A ^a   Vishvanath, Lavanya ^a   Morselli, Eugenia ^a   Amelotte, Mason ^a   Palmer, Biff F ^a   Gupta, Rana K ^a   Scherer, Philipp E ^a   Clegg, Deborah J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Ulsan National Institute of Science and Technology   (South Korea)

Author keywords

Adipose tissue; Estrogen; Fibrosis; Inflammation; Metabolic syndrome; Obesity

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA1; COLLAGEN TYPE 3; COLLAGEN TYPE 3 ALPHA1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HYPOXIA INDUCIBLE FACTOR 1; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL 4 HYDROXYLASE 3; PROTEIN LYSINE 6 OXIDASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; FIBROSIS; GENE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PHD3 GENE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; UBIQUITINATION;

EID: 84906239136     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2014.05.007     Document Type: Article

References (47)

1. Lackey D.E., Burk D.H., Ali M.R., Mostaedi R., Smith W.H., Park J., et al. Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity. American Journal of Physiology. Endocrinology and Metabolism 2014, 306:E233-E246.
2. Asterholm I.W., Halberg N., Scherer P.E. Mouse models of lipodystrophy key reagents for the understanding of the metabolic syndrome. Drug Discovery Today: Disease Models 2007, 4:17-24.
3. Nickelson K.J., Stromsdorfer K.L., Pickering R.T., Liu T.W., Ortinau L.C., Keating A.F., et al. A comparison of inflammatory and oxidative stress markers in adipose tissue from weight-matched obese male and female mice. Experimental Diabetes Research 2012, 2012:859395.
4. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews Molecular Cell Biology 2008, 9:367-377.
5. Divoux A., Tordjman J., Lacasa D., Veyrie N., Hugol D., Aissat A., et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 2010, 59:2817-2825.
6. Khan T., Muise E.S., Iyengar P., Wang Z.V., Chandalia M., Abate N., et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Molecular and Cell Biology 2009, 29:1575-1591.
7. Halberg N., Khan T., Trujillo M.E., Wernstedt-Asterholm I., Attie A.D., Sherwani S., et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Molecular Cell Biology 2009, 29:4467-4483.
8. Sun K., Halberg N., Khan M., Magalang U.J., Scherer P.E. Selective inhibition of hypoxia-inducible factor 1alpha ameliorates adipose tissue dysfunction. Molecular Cell Biology 2013, 33:904-917.
9. Davis K.E., Neinast M.D., Sun K., Skiles W.M., Bills J.D., Zehr J.A., Clegg D.J. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Molecular Metabolism 2013, 2:227-242.
10. Ribas V., Nguyen M.T., Henstridge D.C., Nguyen A.K., Beaven S.W., Watt M.J., et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. American Journal of Physiology. Endocrinology and Metabolism 2010, 298:E304-E319.
11. Rogers N.H., Perfield J.W., Strissel K.J., Obin M.S., Greenberg A.S. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009, 150:2161-2168.
12. Stubbins R.E., Holcomb V.B., Hong J., Nunez N.P. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. European Journal of Nutrition 2012, 51:861-870.
13. Stubbins R.E., Najjar K., Holcomb V.B., Hong J., Nunez N.P. Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes, Obesity and Metabolism 2012, 14:58-66.
14. Rausch M.E., Weisberg S., Vardhana P., Tortoriello D.V. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. International Journal of Obesity (London) 2008, 32:451-463.
15. Xu J., Xiang Q., Lin G., Fu X., Zhou K., Jiang P., et al. Estrogen improved metabolic syndrome through down-regulation of VEGF and HIF-1alpha to inhibit hypoxia of periaortic and intra-abdominal fat in ovariectomized female rats. Molecular Biology Reports 2012, 39:8177-8185.
16. Hodson L. Adipose tissue oxygenation: effects on metabolic function. Adipocyte 2014, 3:75-80.
17. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56:901-911.
18. Ye J., Gao Z., Yin J., He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. American Journal of Physiology. Endocrinology and Metabolism 2007, 293:E1118-E1128.
19. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:7987-7992.
20. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340.
21. Semenza G.L. Hypoxia-inducible factor 1 and cardiovascular disease. Annual Review of Physiology 2014, 76:39-56.
22. Sun K., Kusminski C.M., Scherer P.E. Adipose tissue remodeling and obesity. Journal of Clinical Investigation 2011, 121:2094-2101.
23. Shi H., Clegg D.J. Sex differences in the regulation of body weight. Physiology & Behavior 2009, 97:199-204.
24. Fox C.S., Massaro J.M., Hoffmann U., Pou K.M., Maurovich-Horvat P., Liu C.Y., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
25. Liu J., Fox C.S., Hickson D.A., May W.D., Hairston K.G., Carr J.J., et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. Journal of Clinical Endocrinology & Metabolism 2010, 95:5419-5426.
26. Mauvais-Jarvis F., Clegg D.J., Hevener A.L. The role of estrogens in control of energy balance and glucose homeostasis. Endocrine Reviews 2013, 34:309-338.
27. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:12729-12734.
28. Ferrara C.M., Lynch N.A., Nicklas B.J., Ryan A.S., Berman D.M. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. Journal of Clinical Endocrinology & Metabolism 2002, 87:4166-4170.
29. Carr M.C. The emergence of the metabolic syndrome with menopause. Journal of Clinical Endocrinology & Metabolism 2003, 88:2404-2411.
30. Choi E.K., Kim W.K., Sul O.J., Park Y.K., Kim E.S., Suh J.H., et al. TNFRSF14 deficiency protects against ovariectomy-induced adipose tissue inflammation. Journal of Endocrinology 2014, 220:25-33.
31. Choi J.S., Koh I.-U., Song J. Genistein reduced insulin resistance index through modulating lipid metabolism in ovariectomized rats. Nutrition Research 2012, 32:844-855.
32. Hong H.K., Cho Y.M., Park K.H., Lee C.T., Lee H.K., Park K.S. Peroxisome proliferator-activated receptor gamma mediated inhibition of plasminogen activator inhibitor type 1 production and proliferation of human umbilical vein endothelial cells. Diabetes Research and Clinical Practice 2003, 62:1-8.
33. Seth P., Krop I., Porter D., Polyak K. Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression). Oncogene 2002, 21:836-843.
34. Berry R., Church C.D., Gericke M.T., Jeffery E., Colman L., Rodeheffer M.S. Imaging of adipose tissue. Methods in Enzymology 2014, 537:47-73.
35. Cho J., Kim D., Lee S., Lee Y. Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells. Molecular Endocrinology 2005, 19:1191-1199.
36. Miyauchi Y., Sato Y., Kobayashi T., Yoshida S., Mori T., Kanagawa H., et al. HIF1alpha is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:16568-16573.
37. Mak P., Chang C., Pursell B., Mercurio A.M. Estrogen receptor beta sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:4708-4713.
38. Higgins D.F., Kimura K., Bernhardt W.M., Shrimanker N., Akai Y., Hohenstein B., et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. Journal of Clinical Investigation 2007, 117:3810-3820.
39. Yi P., Driscoll M.D., Huang J., Bhagat S., Hilf R., Bambara R.A., et al. The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta. Molecular Endocrinology (Baltimore, Md.) 2002, 16:674-693.
40. Marino M., Galluzzo P., Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Current Genomics 2006, 7:497-508.
41. Berra E., Benizri E., Ginouves A., Volmat V., Roux D., Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO Journal 2003, 22:4082-4090.
42. Ginouves A., Ilc K., Macias N., Pouyssegur J., Berra E. PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:4745-4750.
43. Place T.L., Nauseef J.T., Peterson M.K., Henry M.D., Mezhir J.J., Domann F.E. Prolyl-4-hydroxylase 3 (PHD3) expression is downregulated during epithelial-to-mesenchymal transition. PLoS ONE 2013, 8:e83021.
44. Peurala E., Koivunen P., Bloigu R., Haapasaari K.M., Jukkola-Vuorinen A. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients. Breast Cancer Research and Treatment 2012, 133:179-188.
45. Tennant D.A., Gottlieb E. HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression. Journal of Molecular Medicine (Berlin) 2010, 88:839-849.
46. Taniguchi C.M., Finger E.C., Krieg A.J., Wu C., Diep A.N., LaGory E.L., et al. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes. Nature Medicine 2013, 19:1325-1330.
47. Rabinowitz M.H. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses. Journal of Medicinal Chemistry 2013, 56:9369-9402.